Pataigin in the news

SEATTLE, WA – 30 March, 2026 – Microbiology diagnostics company Pataigin today appointed Michael Chen as Medical Director to facilitate implementation of BACLIB in the clinical diagnostic lab.

SEATTLE, WA – 30 March, 2022 – Microbiology diagnostics company Pataigin today appointed Deborah A. Elvins as an advisor to the company on business strategy and other business matters.

LISBON, Portugal: Results will be presented from a study of Pataigin’s rapid bacterial ID assay, direct from clinical specimens.

VIENNA, Austria, BALTIMORE Maryland, and SEATTLE, Washington – 13 July 2021: At the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID, www.eccmid.org), Pataigin introduced the BACLIB Rapid Lipid Extraction Kit for microbial identification and colistin resistance detection.

Today, the US NIH awarded Pataigin a research grant to further development of Pataigin’s Rigel antimicrobial susceptibility test.

Today, Pataigin founder Prof. Robert Ernst presented results of a new assay that determines microbial ID and colistin resistance in one hour, direct from clinical specimens. The assay uses lipid microbiology with the FLAT extraction technique to allow colistin resistance to be rapidly determined without culture.

Scientific Reports today published a paper describing the FLAT rapid extraction method that allows identification of bacteria and fungi in one hour. Determination of colistin resistance in Gram-negative bacteria is also demonstrated. The paper was authored by Pataigin personnel in collaboration with the labs of BACLIB inventors Prof. Robert Ernst and Prof. David Goodlett.

Pataigin Director of Development Matthew Sorensen made an oral presentation at the 2020 American Society for Mass Spectrometry conference. The subject of Sorensen’s talk was Rigel, a technology developed at Pataigin under Sorensen’s leadership for mass spectrometry-based antimicrobial susceptibility testing.

Professor Robert Ernst, a founder of Pataigin, has been named the 2019 University of Maryland, Baltimore Entrepreneur of the Year. Prof. Ernst is Professor and Vice Chair, Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore (UMB). This prestigious award was made in part for Ernst’s work in translating his research into Pataigin.

In a paper published in Scientific Reports, Pataigin collaborators demonstrated identification of the ESKAPE pathogens using the BACLIB method licenses by Pataigin.